Typically, these criteria were based on early studies of BRCA1 and BRCA2 and are based on age at breast cancer diagnosis, ethnicity (e.g., Jewish), clinical characteristics of breast cancer (e.g., bilateral breast cancer, triple‐negative breast cancer), and family history of cancer. The gene discussed is BRCA2; the disease is breast cancer.